37 results
8-K
EX-99.1
COGT
Cogent Biosciences Inc
7 May 24
Cogent Biosciences Reports First Quarter 2024 Financial Results
8:19am
in the quarter was $51.2 million, including a non-recurring payment of $8.6 million related to annual performance-based bonus compensation. Based
8-K
EX-10.1
f5b v8elnd5o5ngnr2j
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-99.1
ldo5tghyochca0ded
9 May 23
Cogent Biosciences Reports Recent Business Highlights and First Quarter
8:13am
8-K
arzlb
27 Dec 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
3xhzq fk67q
27 Dec 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
792dlmop uunc4
27 Dec 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
l8ra1wsqq
9 Jul 21
Entry into a Material Definitive Agreement
4:01pm